Buy & Sell AbbVie Inc (ABBV) – AbbVie Inc Price Today
Aura AI Summary
Key Stats
- $390.87BMarket Cap
- HealthSector
- -9.23%3M Drawdown
- $454.33BEnterprise Value
- 3.13%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 90 daysTypical Hold Time
AbbVie Inc (ABBV) is currently valued at a market capitalization of $390.87B, with an enterprise value of $454.33B. Over the past 52 weeks, AbbVie Inc has traded between a low of $182.31 and a high of $244.38, highlighting its annual price range. Over the past three months, AbbVie Inc has recorded a drawdown of -9.23%, reflecting recent price volatility. AbbVie Inc offers a dividend yield of 3.13%, with the most recent dividend of $1.73 paid on 15 Apr 26. On average, investors hold AbbVie Inc for approximately 90 days, indicating typical investor behavior on the platform.
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Most Recent News
Scorpio Tankers updates Q2 2026 daily TCE rates and shares outlook amid fleet changes.
Scorpio Tankers Inc. announced updated daily Time Charter Equivalent (TCE) rates for Q2 2026, reflecting their fleet's contracted voyages and time charters. The company expects diluted shares outstanding between 53 to 54 million for the quarter, fact...

Data center growth drives massive surge in aluminum and copper demand beyond servers.
New research from Wood Mackenzie reveals that the metals demand for data centers extends far beyond servers to include extensive power infrastructure like grid upgrades, transmission lines, and on-site power generation. This broader view shows alumin...

Man Group PLC reduces its long position in Senior Plc shares and derivatives below 1.6%.
Man Group PLC disclosed a reduction in its long position in Senior Plc, holding 1.58% of relevant securities as of June 17, 2026. The firm sold shares and reduced its equity swap positions, signaling a strategic adjustment in its investment. This dis...
